文献速递甲状腺与颈部外科围术期管理与 ERAS

机器人BABA甲状腺切除术中甲状旁腺ICG荧光成像的定量优化

Quantitative optimisation of indocyanine green fluorescence for parathyroid imaging in robotic BABA thyroidectomy: a prospective cohort study.
PubMed 文献 · Surg Endosc · 2026-06-20

本研究在72例低风险甲状腺乳头状癌患者中,对机器人BABA甲状腺切除术中甲状旁腺ICG荧光成像进行定量优化,提出以相对荧光强度比(RFIR)阈值1.07和帧 majority 规则定义良好成像,并发现较低ICG剂量(1.5-2.0 mL)和较低空腹血糖与更优图像质量相关,而3.0 mL剂量和高空腹血糖则降低良好成像几率。

要点

  • RFIR阈值1.07可区分清晰与不清晰图像,AUC为0.832。
  • 病例水平良好成像定义为至少6/12帧(≥50%)RFIR≥1.07。
  • 低剂量ICG(1.5-2.0 mL)和低空腹血糖预测最佳成像。

核心结论

  • 机器人BABA甲状腺切除术中甲状旁腺ICG荧光成像可用RFIR阈值1.07和帧多数规则标准化。
  • 较低ICG剂量(1.5-2.0 mL)和有利代谢状态(低空腹血糖)是优化图像质量的关键决定因素。
  • 较高剂量(3.0 mL)和高空腹血糖与过饱和及对比度降低相关。

研究设计与样本

  • 单中心前瞻性队列研究,纳入2024年6月至2025年1月共72例低风险甲状腺乳头状癌患者。
  • 患者接受da Vinci Xi系统机器人BABA甲状腺切除术并应用ICG荧光成像。
  • 采用循环剂量方案(1.5、2.0、2.5、3.0 mL),每例记录12秒荧光序列并提取12帧进行分析。

主要发现

  • RFIR截断值1.07区分清晰与不清晰图像的曲线下面积为0.832。
  • 单变量分析中,较高体重指数与良好成像正相关(OR 1.18,95%CI 1.03-1.36;P=0.020)。
  • 单变量分析中,ICG剂量3.0 mL与良好成像负相关(OR 0.11,95%CI 0.02-0.50;P=0.004)。
  • 多变量分析中,较高空腹血糖(OR 0.25,95%CI 0.08-0.86;P=0.027)和ICG剂量3.0 mL(OR 0.01,95%CI 0.00-0.17;P=0.001)独立 associated with reduced odds of good imaging。
  • 交互分析显示低空腹血糖联合较低剂量(1.5-2.0 mL)预测最佳成像概率最高,而高空腹血糖联合较高剂量(2.5-3.0 mL)表现最差。

关键数值与推荐

  • RFIR阈值1.07用于区分清晰与不清晰图像。
  • 病例水平良好成像定义为至少6/12帧(≥50%)RFIR≥1.07。

临床怎么用

  • 可采用RFIR阈值1.07和帧多数规则标准化甲状旁腺ICG荧光成像评估。
  • 优先选择较低ICG剂量(1.5-2.0 mL)以优化图像质量。
  • 对空腹血糖较高的患者,需注意图像质量可能下降。

局限性

  • 单中心前瞻性研究,样本量有限。
  • 研究人群为低风险甲状腺乳头状癌患者,结果外推需谨慎。
  • 未报告术后钙和甲状旁腺功能结局的关联数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop and validate a quantitative framework for intraoperative indocyanine green (ICG) fluorescence imaging of the parathyroid glands during robotic bilateral axillo-breast approach (BABA) thyroidectomy and to identify technical and clinical factors associated with optimal image quality. BACKGROUND: ICG fluorescence is increasingly used to aid parathyroid identification and perfusion assessment in thyroid surgery, but there is no consensus on optimal dosing, image quantification, or patient selection, particularly in the context of robotic thyroidectomy. A robust, objective definition of "good" imaging is needed to standardise protocols and support broader clinical adoption. METHODS: In this single-centre prospective study (June 2024-January 2025), 72 consecutive patients with low-risk papillary thyroid carcinoma underwent robotic BABA thyroidectomy with ICG fluorescence using the da Vinci Xi system. A cyclic dosing protocol (1.5, 2.0, 2.5, 3.0 mL) was applied in eligible cases. For each patient, a 12-s fluorescence sequence was recorded from the onset of visible ICG uptake, and 12 frames (1 frame per second) were extracted. In each frame, the parathyroid region (Zone A) and periparathyroid background (Zone C) were manually segmented, and the relative fluorescence intensity ratio (RFIR = A/C) was calculated. Image quality was independently graded on a 3-point scale (0-2) and classified as clear (mean score ≥ 1) or unclear (< 1). Receiver operating characteristic analysis was used to derive an RFIR threshold for "good" imaging. Univariable and multivariable logistic regression were performed to explore associations between imaging quality and clinical variables (demographics, biochemistry, thyroiditis, fasting blood glucose [FBG], intraoperative haemodynamics) and ICG dose. RESULTS: An RFIR cut-off of 1.07 yielded an area under the curve of 0.832 for discrimination between clear and unclear images. At the case level, imaging was defined as good when at least 6 of 12 frames (≥ 50%) had RFIR ≥ 1.07. In univariable analysis, higher body mass index was positively associated with good imaging (odds ratio [OR] 1.18, 95% confidence interval [CI] 1.03-1.36; P = 0.020), whereas an ICG dose of 3.0 mL was negatively associated (OR 0.11, 95% CI 0.02-0.50; P = 0.004). In multivariable analysis, elevated FBG (OR 0.25, 95% CI 0.08-0.86; P = 0.027) and an ICG dose of 3.0 mL (OR 0.01, 95% CI 0.00-0.17; P = 0.001) remained independently associated with reduced odds of good imaging, while other clinical and haemodynamic variables were not significant. Interaction analyses showed that low FBG combined with lower doses (1.5-2.0 mL) provided the highest predicted probability of optimal imaging, whereas high FBG with higher doses (2.5-3.0 mL) yielded the poorest performance. CONCLUSIONS: ICG fluorescence imaging of the parathyroid glands during robotic BABA thyroidectomy can be standardised using an RFIR threshold of 1.07 and a frame-based majority rule to define good imaging. Lower ICG doses (1.5-2.0 mL) and favourable metabolic status (low FBG) are key determinants of optimal image quality, whereas higher doses (3.0 mL) and elevated FBG are associated with over-saturation and reduced contrast. These findings support tailored, low-dose ICG protocols and provide a quantitative benchmark for future multi-centre studies linking fluorescence metrics to postoperative calcium and parathyroid function outcomes.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chi H, Sui C, Yang M, et al. Quantitative optimisation of indocyanine green fluorescence for parathyroid imaging in robotic BABA thyroidectomy: a prospective cohort study. Surg Endosc. 2026. PMID: 42323412. doi:10.1007/s00464-026-13021-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。